Beam Therapeutics Inc. — All Filings
464 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
424B7
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-25-083043 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-083052 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-083050 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-083053 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-083051 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-083054 | Jun 6, 2025 | Jun 4, 2025 |
| SCHEDULE 13G/A | — | 0001072613-25-000405 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000908834-25-000171 | May 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-063955 | May 6, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-063966 | May 6, 2025 | Mar 31, 2025 |
| DEF 14A | DEF 14A | 0000950170-25-055853 | Apr 18, 2025 | Jun 4, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-055857 | Apr 18, 2025 | — |
| ARS | ARS | 0000950170-25-055863 | Apr 18, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001576419-25-000564 | Apr 17, 2025 | — |
| 3 | 3 | 0000950170-25-052693 | Apr 10, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-050859 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | 4 | 0000950170-25-050852 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | 4 | 0000950170-25-050855 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | 4 | 0000950170-25-050856 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | 4 | 0000950170-25-050857 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | 4 | 0000950170-25-049761 | Apr 2, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-001019 | Apr 2, 2025 | — |
| 4 | 4 | 0000950170-25-049763 | Apr 2, 2025 | Mar 31, 2025 |
| 144 | — | 0001950047-25-002326 | Apr 2, 2025 | — |
| 4 | 4 | 0000950170-25-049759 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-049765 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-049769 | Apr 2, 2025 | Mar 31, 2025 |
| 4/A | 4/A | 0000950170-25-049297 | Apr 2, 2025 | Jan 30, 2025 |
| 144 | — | 0000950170-25-047961 | Mar 31, 2025 | — |
| 144 | — | 0000950170-25-047960 | Mar 31, 2025 | — |
| 144 | — | 0000950170-25-047958 | Mar 31, 2025 | — |
| 144 | — | 0000950170-25-047959 | Mar 31, 2025 | — |
| 8-K | 8-K | 0001193125-25-051072 | Mar 10, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-051106 | Mar 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-050334 | Mar 10, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-050343 | Mar 10, 2025 | — |
| FWP | FWP | 0001193125-25-050346 | Mar 10, 2025 | — |
| S-8 | S-8 | 0000950170-25-026086 | Feb 25, 2025 | — |
| 10-K | 10-K | 0000950170-25-026076 | Feb 25, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-026070 | Feb 25, 2025 | — |
| 4 | 4 | 0000950170-25-024149 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | 4 | 0000950170-25-023166 | Feb 19, 2025 | Feb 14, 2025 |
| 144 | — | 0001950047-25-000859 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001072613-25-000167 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000727 | Feb 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000908834-25-000047 | Feb 5, 2025 | — |
| 4 | 4 | 0000950170-25-012303 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | 4 | 0000950170-25-012304 | Feb 3, 2025 | Jan 30, 2025 |
| 4 | 4 | 0000950170-25-012305 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | 4 | 0000950170-25-012306 | Feb 3, 2025 | Jan 31, 2025 |